ACAD
32.11
+0.22
+0.69%
AEMD
1.59
-0.09
-5.36%
APRI
1.35
0.00
0.00%
ARNA
21.27
-0.12
-0.56%
ATEC
1.68
-0.01
-0.59%
CNAT
5.06
-0.1
-1.94%
CRXM
0.159
+0.001
+0.72152%
CYTX
0.35
-0.02
-4.40%
DXCM
71.22
-0.4
-0.56%
GNMK
9.99
-0.1
-0.99%
HALO
11.9
-0.15
-1.24%
ILMN
193.92
-0.88
-0.45%
INNV
0.109
+0.008
+7.921%
INO
5.64
0.00
0.00%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
127.02
+0.1
+0.08%
LPTN
2.93
-2.93
-100.00%
MBVX
0.511
-0.04
-7.1818%
MEIP
2.77
-0.02
-0.72%
MNOV
4.69
+0.09
+1.96%
MRTX
4.9
+0.05
+1.03%
MSTX
0.13
-0.01
-5.28%
NBIX
54.04
+0.06
+0.11%
NUVA
68
+1.3
+1.95%
ONCS
0.92
-0.06
-5.93%
ONVO
2.14
-0.04
-1.83%
OREX
2.43
0.00
0.00%
OTIC
19.45
+2.25
+13.08%
QDEL
32.93
-0.22
-0.66%
RCPT
231.96
0.00
0.00%
RGLS
0.882
-0.057
-6.0390%
RMD
72.44
-0.83
-1.13%
SCIE
0
+0.00
+50.0000%
SPHS
1.85
+0.02
+1.09%
SRNE
1.65
-0.12
-7.04%
TROV
0.8
-0.05
-5.66%
VICL
2.41
-0.06
-2.43%
VOLC
18
0.00
0.00%
ZGNX
11.45
+0.2
+1.78%
ACAD
32.11
+0.22
+0.69%
AEMD
1.59
-0.09
-5.36%
APRI
1.35
0.00
0.00%
ARNA
21.27
-0.12
-0.56%
ATEC
1.68
-0.01
-0.59%
CNAT
5.06
-0.1
-1.94%
CRXM
0.159
+0.001
+0.72152%
CYTX
0.35
-0.02
-4.40%
DXCM
71.22
-0.4
-0.56%
GNMK
9.99
-0.1
-0.99%
HALO
11.9
-0.15
-1.24%
ILMN
193.92
-0.88
-0.45%
INNV
0.109
+0.008
+7.921%
INO
5.64
0.00
0.00%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
127.02
+0.1
+0.08%
LPTN
2.93
-2.93
-100.00%
MBVX
0.511
-0.04
-7.1818%
MEIP
2.77
-0.02
-0.72%
MNOV
4.69
+0.09
+1.96%
MRTX
4.9
+0.05
+1.03%
MSTX
0.13
-0.01
-5.28%
NBIX
54.04
+0.06
+0.11%
NUVA
68
+1.3
+1.95%
ONCS
0.92
-0.06
-5.93%
ONVO
2.14
-0.04
-1.83%
OREX
2.43
0.00
0.00%
OTIC
19.45
+2.25
+13.08%
QDEL
32.93
-0.22
-0.66%
RCPT
231.96
0.00
0.00%
RGLS
0.882
-0.057
-6.0390%
RMD
72.44
-0.83
-1.13%
SCIE
0
+0.00
+50.0000%
SPHS
1.85
+0.02
+1.09%
SRNE
1.65
-0.12
-7.04%
TROV
0.8
-0.05
-5.66%
VICL
2.41
-0.06
-2.43%
VOLC
18
0.00
0.00%
ZGNX
11.45
+0.2
+1.78%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.

Be Sociable, Share!